ERBB2 and neoplasm: In contrast, hPRL-treatment of NOD/SCID mice bearing xenografts of MDA-MB-453 breast cancer cells reduced tumor growth and dissemination (122), and growth of primary HER2+ SKBR3 tumors (131).